Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0F8HN
|
|||
Former ID |
DIB001796
|
|||
Drug Name |
DA-8031
|
|||
Synonyms |
Serotonin transporter inhibitor (premature ejaculation), Dong A
Click to Show/Hide
|
|||
Indication | Premature ejaculation [ICD-11: HA03.0Z; ICD-10: F52.4; ICD-9: 302.75] | Phase 2 | [1] | |
Company |
Dong-A Pharmaceutical Co Ltd
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Serotonin transporter (SERT) | Target Info | Inhibitor | [2] |
KEGG Pathway | Serotonergic synapse | |||
NetPath Pathway | TCR Signaling Pathway | |||
Panther Pathway | 5HT1 type receptor mediated signaling pathway | |||
5HT2 type receptor mediated signaling pathway | ||||
5HT3 type receptor mediated signaling pathway | ||||
5HT4 type receptor mediated signaling pathway | ||||
WikiPathways | Monoamine Transport | |||
SIDS Susceptibility Pathways | ||||
NRF2 pathway | ||||
Synaptic Vesicle Pathway | ||||
Serotonin Transporter Activity |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT01798667) Clinical Trial to Evaluate the Efficacy and Safety of DA-8031 in Male Patients With Premature Ejaculation. U.S. National Institutes of Health. | |||
REF 2 | Effect of DA-8031, a novel oral compound for premature ejaculation, on male rat sexual behavior. Int J Urol. 2014 Mar;21(3):325-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.